Rising Bone Health Awareness Driven by GLP-1 Usage and Early Screening Trends

Story Summary
Increased clinical focus on bone density is emerging as a significant wellness trend, largely attributed to the widespread use of GLP-1 weight-loss medications, which can accelerate bone loss. Endocrinologist Dr. Caroline Messer notes that while standard screening typically begins at age 65, earlier intervention is becoming necessary. Maintaining skeletal health requires consistent calcium, vitamin D, protein intake, and weight-bearing exercise.





